CL2015002152A1 - Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh - Google Patents

Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh

Info

Publication number
CL2015002152A1
CL2015002152A1 CL2015002152A CL2015002152A CL2015002152A1 CL 2015002152 A1 CL2015002152 A1 CL 2015002152A1 CL 2015002152 A CL2015002152 A CL 2015002152A CL 2015002152 A CL2015002152 A CL 2015002152A CL 2015002152 A1 CL2015002152 A1 CL 2015002152A1
Authority
CL
Chile
Prior art keywords
vrsh
hybridomas
secreted
antigen
diagnosis
Prior art date
Application number
CL2015002152A
Other languages
English (en)
Inventor
Ramirez Susan Marcela Bueno
Parra Alexis Mikes Kalergis
Alarcon Jorge Eugenio Mora
Original Assignee
Pontificia Universidad Católica De Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pontificia Universidad Católica De Chile filed Critical Pontificia Universidad Católica De Chile
Priority to CL2015002152A priority Critical patent/CL2015002152A1/es
Publication of CL2015002152A1 publication Critical patent/CL2015002152A1/es
Priority to KR1020187005939A priority patent/KR102679351B1/ko
Priority to BR112018002031-1A priority patent/BR112018002031B1/pt
Priority to PT168323871T priority patent/PT3328884T/pt
Priority to EP18203701.0A priority patent/EP3517546B1/en
Priority to RU2018103933A priority patent/RU2716990C2/ru
Priority to EP16832387.1A priority patent/EP3328884B1/en
Priority to MX2018001244A priority patent/MX2018001244A/es
Priority to CN201680052944.0A priority patent/CN108474017B/zh
Priority to PCT/IB2016/054424 priority patent/WO2017021815A2/en
Priority to PT182037010T priority patent/PT3517546T/pt
Priority to PE2018000144A priority patent/PE20180576A1/es
Priority to PE2021001936A priority patent/PE20220004A1/es
Priority to US15/748,979 priority patent/US10858419B2/en
Priority to CA2994219A priority patent/CA2994219C/en
Priority to ES16832387T priority patent/ES2784888T3/es
Priority to ES18203701T priority patent/ES2786637T3/es
Priority to UY0001036820A priority patent/UY36820A/es
Priority to ARP160102326A priority patent/AR105541A1/es
Priority to MX2022010471A priority patent/MX2022010471A/es
Priority to CONC2018/0001010A priority patent/CO2018001010A2/es
Priority to ZA2018/00938A priority patent/ZA201800938B/en
Priority to US17/087,103 priority patent/US11873331B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • C07K16/11Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
CL2015002152A 2015-07-31 2015-07-31 Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh CL2015002152A1 (es)

Priority Applications (23)

Application Number Priority Date Filing Date Title
CL2015002152A CL2015002152A1 (es) 2015-07-31 2015-07-31 Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh
ES18203701T ES2786637T3 (es) 2015-07-31 2016-07-25 Anticuerpo monoclonal específico para la proteína P del Virus Respiratorio Sincicial humano y uso del mismo para la detección y diagnóstico de infección por VRS
PT182037010T PT3517546T (pt) 2015-07-31 2016-07-25 Anticorpo monoclonal específico para a proteína p do vírus sincicial respiratório humano e seu uso para a deteção e o diagnóstico de infeção por rsv
PE2021001936A PE20220004A1 (es) 2015-07-31 2016-07-25 Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh
PT168323871T PT3328884T (pt) 2015-07-31 2016-07-25 Anticorpo monoclonal específico para a proteína p do vírus sincicial respiratório humano e seu uso para a deteção e o diagnóstico de infeção por rsv
EP18203701.0A EP3517546B1 (en) 2015-07-31 2016-07-25 Monoclonal antibody specific for protein p of the human respiratory syncytial virus and use thereof for the detection and diagnosis of rsv infection
RU2018103933A RU2716990C2 (ru) 2015-07-31 2016-07-25 Моноклональные антитела с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом
EP16832387.1A EP3328884B1 (en) 2015-07-31 2016-07-25 Monoclonal antibody specific for protein p of the human respiratory syncytial virus and use thereof for the detection and diagnosis of rsv infection
MX2018001244A MX2018001244A (es) 2015-07-31 2016-07-25 Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh.
CN201680052944.0A CN108474017B (zh) 2015-07-31 2016-07-25 用于检测呼吸道合胞病毒抗原p的单克隆抗体
PCT/IB2016/054424 WO2017021815A2 (en) 2015-07-31 2016-07-25 Monoclonal antibodies specifically for the antigen p of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by rsv
KR1020187005939A KR102679351B1 (ko) 2015-07-31 2016-07-25 인간 호흡기 세포융합 바이러스의 인단백질에 특이적인 단클론 항체 및 사용 방법
PE2018000144A PE20180576A1 (es) 2015-07-31 2016-07-25 ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh
BR112018002031-1A BR112018002031B1 (pt) 2015-07-31 2016-07-25 Anticorpo monoclonal ou um fragmento do mesmo que se liga àproteína p do vírus sincicial respiratório humano (vsr), conjunto desequências de nucleotídeos que codificam o referido anticorpo monoclonalou fragmento do mesmo, método in vitro e/ou ex vivo para diagnóstico deinfecção por vsr em uma amostra biológica e kit de diagnóstico para detectarvsr
US15/748,979 US10858419B2 (en) 2015-07-31 2016-07-25 Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV
CA2994219A CA2994219C (en) 2015-07-31 2016-07-25 Monoclonal antibodies specifically for the antigen p of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by rsv.
ES16832387T ES2784888T3 (es) 2015-07-31 2016-07-25 Anticuerpo monoclonal específico para la proteína P del Virus Respiratorio Sincicial humano y uso del mismo para la detección y diagnóstico de infección por VRS
UY0001036820A UY36820A (es) 2015-07-31 2016-07-27 Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por vrsh
ARP160102326A AR105541A1 (es) 2015-07-31 2016-07-29 ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR VRSh
MX2022010471A MX2022010471A (es) 2015-07-31 2018-01-29 Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh.
CONC2018/0001010A CO2018001010A2 (es) 2015-07-31 2018-01-30 Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por vrsh
ZA2018/00938A ZA201800938B (en) 2015-07-31 2018-02-12 Monoclonal antibodies specifically for phosphoprotein of the human respiratory syncytial virus and the methods of use
US17/087,103 US11873331B2 (en) 2015-07-31 2020-11-02 Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2015002152A CL2015002152A1 (es) 2015-07-31 2015-07-31 Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh

Publications (1)

Publication Number Publication Date
CL2015002152A1 true CL2015002152A1 (es) 2016-06-03

Family

ID=56610056

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015002152A CL2015002152A1 (es) 2015-07-31 2015-07-31 Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh

Country Status (16)

Country Link
US (2) US10858419B2 (es)
EP (2) EP3328884B1 (es)
KR (1) KR102679351B1 (es)
CN (1) CN108474017B (es)
AR (1) AR105541A1 (es)
CA (1) CA2994219C (es)
CL (1) CL2015002152A1 (es)
CO (1) CO2018001010A2 (es)
ES (2) ES2784888T3 (es)
MX (2) MX2018001244A (es)
PE (2) PE20180576A1 (es)
PT (2) PT3517546T (es)
RU (1) RU2716990C2 (es)
UY (1) UY36820A (es)
WO (1) WO2017021815A2 (es)
ZA (1) ZA201800938B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017127857B4 (de) * 2017-11-24 2023-10-12 Lipozyt Marker UG (haftungsbeschränkt) Verwendung des ADIPOQ Genexpressionslevels zur Einordnung eines Probanden in Risikogruppen bei der Prognose oder Diagnose einer Diabetes mellitus Typ II Erkrankung
EP3848389A4 (en) * 2018-09-03 2022-04-13 Pontificia Universidad Católica De Chile SPECIFIC MONOCLONAL ANTIBODIES AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) N-ANTIGEN FOR TREATMENT, DETECTION AND DIAGNOSIS OF INFECTION
CL2018003869A1 (es) * 2018-12-28 2021-01-15 Univ Pontificia Catolica Chile Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv
EP3825591B1 (en) 2019-11-22 2025-08-06 Hamilton Sundstrand Corporation Hydraulic damping valve
CN113354734B (zh) * 2021-07-14 2021-12-14 北京祥瑞生物制品有限公司 一种快速检测病毒的试剂盒及其制备方法
CN115925909B (zh) * 2022-09-27 2023-07-21 深圳重链生物科技有限公司 抗呼吸道合胞病毒抗体及其相关应用
CN115838419B (zh) * 2022-09-27 2023-06-30 深圳重链生物科技有限公司 抗呼吸道合胞病毒抗体及其相关应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824307A (en) 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
US7223410B1 (en) * 1994-08-05 2007-05-29 Sanofi Pasteur Limited Inactivated respiratory syncytial viral vaccines
US6258529B1 (en) * 1994-12-01 2001-07-10 Oravax, Inc. PCR amplification of rearranged genomic variable regions of immunoglobulin genes
US7527787B2 (en) * 2005-10-19 2009-05-05 Ibc Pharmaceuticals, Inc. Multivalent immunoglobulin-based bioactive assemblies
US20040096451A1 (en) 2002-07-25 2004-05-20 Young James F. Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
EP1485468A4 (en) * 2002-02-21 2007-01-03 Medimmune Vaccines Inc RECOMBINANT PARAIN FLUENZAVIRUS EXPRESSION SYSTEMS AND VACCINES WITH ANTIGENS FROM METAPNEUMOVIRUS STEM-RELATED HETEROLOGISTS
JP2007531491A (ja) * 2002-09-27 2007-11-08 メディミューン・ヴァクシンズ・インコーポレーテッド 呼吸器合胞体ウイルスにおける機能的突然変異
RU2008110058A (ru) * 2005-08-15 2009-09-27 Арана Терапьютикс Лимитед (Au) Химерные антитела с областями приматов нового света
CA2742157A1 (en) * 2008-10-31 2010-05-06 Toray Industries, Inc. Immunoassay method for human cxcl1 protein
CL2011003002A1 (es) * 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.

Also Published As

Publication number Publication date
RU2018103933A (ru) 2019-08-28
PE20220004A1 (es) 2022-01-05
KR102679351B1 (ko) 2024-06-27
UY36820A (es) 2017-01-31
US11873331B2 (en) 2024-01-16
EP3328884A2 (en) 2018-06-06
EP3328884B1 (en) 2020-01-01
WO2017021815A3 (en) 2017-05-11
WO2017021815A2 (en) 2017-02-09
ES2784888T3 (es) 2020-10-01
PE20180576A1 (es) 2018-04-04
RU2716990C2 (ru) 2020-03-17
US20210070844A1 (en) 2021-03-11
BR112018002031A2 (pt) 2018-09-11
KR20180030919A (ko) 2018-03-26
CO2018001010A2 (es) 2018-04-30
CA2994219A1 (en) 2017-02-09
CN108474017B (zh) 2021-08-27
ES2786637T3 (es) 2020-10-13
CN108474017A (zh) 2018-08-31
EP3328884A4 (en) 2018-06-06
PT3328884T (pt) 2020-04-08
AR105541A1 (es) 2017-10-11
US10858419B2 (en) 2020-12-08
EP3517546B1 (en) 2020-02-26
RU2018103933A3 (es) 2019-08-28
MX2018001244A (es) 2018-04-24
US20180327483A1 (en) 2018-11-15
EP3517546A1 (en) 2019-07-31
MX2022010471A (es) 2022-09-19
ZA201800938B (en) 2019-07-31
CA2994219C (en) 2024-02-20
PT3517546T (pt) 2020-05-22

Similar Documents

Publication Publication Date Title
CL2015002152A1 (es) Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh
PT3368562T (pt) Anticorpo neutralizante do vírus sincicial respiratório humano
UY36905A (es) Anticuerpos neutralizantes de poliomavirus
JOP20170004B1 (ar) الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته
EP3532489A4 (en) ANTI-TL1A NEUTRALIZING MONOCLONAL ANTIBODIES
HUE053719T2 (hu) CTLA4 elleni monoklonális ellenanyag vagy annak antigénkötõ fragmentuma, gyógyásztati készítmény és alkalmazás
LT3390441T (lt) Žmogaus imunodeficito virusą neutralizuojantys antikūnai
EP3589648A4 (en) MONOCLONAL ANTI-RSV ANTIBODY FORMULATION
CL2017001610A1 (es) Anticuerpos humanos para hemagglutinina de influenza
IL250032B (en) Anti-pd-l1 antibodies and diagnostic uses thereof
HUE049083T2 (hu) Humanizált, humán CD19 elleni antitestek és alkalmazási eljárások
EA201500995A1 (ru) Биспецифические антитела, специфические в отношении fap и dr5, антитела, специфические в отношении dr5, и способы их применения
EP3470427A4 (en) Anti-human interleukin-17a monoclonal antibody, and preparation method and use thereof
EA201591973A1 (ru) Антитела человека, связывающиеся с g-белком rsv
HUE040234T2 (hu) Humanizált anti-CD134 (OX40) antitestek és felhasználásaik
EA201600473A1 (ru) ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К Tau(PS422) И СПОСОБЫ ПРИМЕНЕНИЯ
LT3390450T (lt) Antii-cd28 humanizuoti antikūnai, paruošti vartoti žmonėms
MX349235B (es) Anticuerpos monoclonales específicos para el antígeno m2-1 del virus respiratorio sincicial (vrs).
ZA201804705B (en) Monoclonal antibodies specific for the piii antigen of human adenovirus (adv), produced and secreted by cell hybridomas, useful for detection and diagnosis of adv infection
CL2014003373A1 (es) Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv.
HUE052528T2 (hu) Anti szklerosztin antitest, antigénkötõ fragmens és annak orvosi használata
EP3212666A4 (en) Human monoclonal antibody specific for the f protein of respiratory syncytial virus (rsv)
CL2018003871A1 (es) Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu
CL2016002046A1 (es) Anticuerpos monoclonales específicos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por hmpv.
CL2016002710A1 (es) Anticuerpos monoclonales específicos para cry1ca y métodos de detección relacionados